November 29 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Friday that its net profit excluding minority interest rose to 33.8 million levs ($19.0 million/17.3 million euro) in the first nine months of 2019 from 27 million levs in the same period of last year.